Status:
COMPLETED
National Cooperative Growth Study in CKD
Lead Sponsor:
University of California, Davis
Collaborating Sponsors:
Genentech, Inc.
Conditions:
Growth Hormone Deficiency
Eligibility:
All Genders
1-18 years
Brief Summary
The purpose of this study is to learn whether growth hormone being administered to children with Chronic Kidney Disease is effective and if it has any side effects.
Eligibility Criteria
Inclusion
- Must be a patient of the UC Davis Medical Center pediatric clinic with Chronic Kidney Disease
Exclusion
- Greater than 18 years old
- Not a patient at the UC Davis Medical Center pediatric clinic
Key Trial Info
Start Date :
October 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2010
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT00616278
Start Date
October 1 2005
End Date
February 1 2010
Last Update
May 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UC Davis Medical Center
Sacramento, California, United States, 95817